Report Detail
Global Compounding Chemotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4356878 |
- 02 December, 2021 |
- Global |
- 112 Pages |
- QYResearch |
- Medical Industry
Summary:
The compounding chemotherapy market is showing significant growth. Compounding of drugs makes them patient-specific which is the biggest advantage. Compounding chemotherapy can minimize the risk of underdose or overdose of drugs for a patient. Therefore, owing to its numerous advantages.
Market Insights
QY Research has lately published a report titled “Global Compounding Chemotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Compounding Chemotherapy market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Gravimetric Automated Compounding Device (Weight-Based)
Volumetric Automated Compounding Device (Volume-Based)
Segment by Application
Breast Cancer
Blood Cancer
Prostate Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Others
Regional Scope
This segment of the report offers a thorough regional study of the global Compounding Chemotherapy market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Braun Melsungen AG
Pfizer Inc.
Baxter
Grifols SA
The Metrix Company
Added Pharma
Equashield
Millers Pharmacy
Comecer S.P.A.
Omnicell
Icon group
Dedalus Group
Arxium
Sterline S.R.L.
Loccioni
Frequently Asked Questions
Which application segment captured the leading share in the Compounding Chemotherapy market?
How fragmented is the Compounding Chemotherapy market?
Which are the key growth drivers in the Compounding Chemotherapy market?
Which are the top strategies undertaken by the Compounding Chemotherapy market players?
Which technological trends are likely to affect the Compounding Chemotherapy market?
What is the expected Compounding Chemotherapy market size by 2027?
Which companies are dominating the Compounding Chemotherapy market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Compounding Chemotherapy market growth?
Which are the emerging companies in the Compounding Chemotherapy market?
Table of Contents
1 Market Overview of Compounding Chemotherapy
- 1.1 Compounding Chemotherapy Market Overview
- 1.1.1 Compounding Chemotherapy Product Scope
- 1.1.2 Compounding Chemotherapy Market Status and Outlook
- 1.2 Global Compounding Chemotherapy Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Compounding Chemotherapy Market Size by Region (2016-2027)
- 1.4 Global Compounding Chemotherapy Historic Market Size by Region (2016-2021)
- 1.5 Global Compounding Chemotherapy Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Compounding Chemotherapy Market Size (2016-2027)
- 1.6.1 North America Compounding Chemotherapy Market Size (2016-2027)
- 1.6.2 Europe Compounding Chemotherapy Market Size (2016-2027)
- 1.6.3 Asia-Pacific Compounding Chemotherapy Market Size (2016-2027)
- 1.6.4 Latin America Compounding Chemotherapy Market Size (2016-2027)
- 1.6.5 Middle East & Africa Compounding Chemotherapy Market Size (2016-2027)
2 Compounding Chemotherapy Market Overview by Type
- 2.1 Global Compounding Chemotherapy Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Compounding Chemotherapy Historic Market Size by Type (2016-2021)
- 2.3 Global Compounding Chemotherapy Forecasted Market Size by Type (2022-2027)
- 2.4 Gravimetric Automated Compounding Device (Weight-Based)
- 2.5 Volumetric Automated Compounding Device (Volume-Based)
3 Compounding Chemotherapy Market Overview by Application
- 3.1 Global Compounding Chemotherapy Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Compounding Chemotherapy Historic Market Size by Application (2016-2021)
- 3.3 Global Compounding Chemotherapy Forecasted Market Size by Application (2022-2027)
- 3.4 Breast Cancer
- 3.5 Blood Cancer
- 3.6 Prostate Cancer
- 3.7 Gastrointestinal Cancer
- 3.8 Respiratory/Lung Cancer
- 3.9 Others
4 Compounding Chemotherapy Competition Analysis by Players
- 4.1 Global Compounding Chemotherapy Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Compounding Chemotherapy as of 2020)
- 4.3 Date of Key Players Enter into Compounding Chemotherapy Market
- 4.4 Global Top Players Compounding Chemotherapy Headquarters and Area Served
- 4.5 Key Players Compounding Chemotherapy Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Compounding Chemotherapy Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Braun Melsungen AG
- 5.1.1 Braun Melsungen AG Profile
- 5.1.2 Braun Melsungen AG Main Business
- 5.1.3 Braun Melsungen AG Compounding Chemotherapy Products, Services and Solutions
- 5.1.4 Braun Melsungen AG Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.1.5 Braun Melsungen AG Recent Developments
- 5.2 Pfizer Inc.
- 5.2.1 Pfizer Inc. Profile
- 5.2.2 Pfizer Inc. Main Business
- 5.2.3 Pfizer Inc. Compounding Chemotherapy Products, Services and Solutions
- 5.2.4 Pfizer Inc. Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.2.5 Pfizer Inc. Recent Developments
- 5.3 Baxter
- 5.3.1 Baxter Profile
- 5.3.2 Baxter Main Business
- 5.3.3 Baxter Compounding Chemotherapy Products, Services and Solutions
- 5.3.4 Baxter Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.3.5 Grifols SA Recent Developments
- 5.4 Grifols SA
- 5.4.1 Grifols SA Profile
- 5.4.2 Grifols SA Main Business
- 5.4.3 Grifols SA Compounding Chemotherapy Products, Services and Solutions
- 5.4.4 Grifols SA Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.4.5 Grifols SA Recent Developments
- 5.5 The Metrix Company
- 5.5.1 The Metrix Company Profile
- 5.5.2 The Metrix Company Main Business
- 5.5.3 The Metrix Company Compounding Chemotherapy Products, Services and Solutions
- 5.5.4 The Metrix Company Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.5.5 The Metrix Company Recent Developments
- 5.6 Added Pharma
- 5.6.1 Added Pharma Profile
- 5.6.2 Added Pharma Main Business
- 5.6.3 Added Pharma Compounding Chemotherapy Products, Services and Solutions
- 5.6.4 Added Pharma Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.6.5 Added Pharma Recent Developments
- 5.7 Equashield
- 5.7.1 Equashield Profile
- 5.7.2 Equashield Main Business
- 5.7.3 Equashield Compounding Chemotherapy Products, Services and Solutions
- 5.7.4 Equashield Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.7.5 Equashield Recent Developments
- 5.8 Millers Pharmacy
- 5.8.1 Millers Pharmacy Profile
- 5.8.2 Millers Pharmacy Main Business
- 5.8.3 Millers Pharmacy Compounding Chemotherapy Products, Services and Solutions
- 5.8.4 Millers Pharmacy Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.8.5 Millers Pharmacy Recent Developments
- 5.9 Comecer S.P.A.
- 5.9.1 Comecer S.P.A. Profile
- 5.9.2 Comecer S.P.A. Main Business
- 5.9.3 Comecer S.P.A. Compounding Chemotherapy Products, Services and Solutions
- 5.9.4 Comecer S.P.A. Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.9.5 Comecer S.P.A. Recent Developments
- 5.10 Omnicell
- 5.10.1 Omnicell Profile
- 5.10.2 Omnicell Main Business
- 5.10.3 Omnicell Compounding Chemotherapy Products, Services and Solutions
- 5.10.4 Omnicell Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.10.5 Omnicell Recent Developments
- 5.11 Icon group
- 5.11.1 Icon group Profile
- 5.11.2 Icon group Main Business
- 5.11.3 Icon group Compounding Chemotherapy Products, Services and Solutions
- 5.11.4 Icon group Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.11.5 Icon group Recent Developments
- 5.12 Dedalus Group
- 5.12.1 Dedalus Group Profile
- 5.12.2 Dedalus Group Main Business
- 5.12.3 Dedalus Group Compounding Chemotherapy Products, Services and Solutions
- 5.12.4 Dedalus Group Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.12.5 Dedalus Group Recent Developments
- 5.13 Arxium
- 5.13.1 Arxium Profile
- 5.13.2 Arxium Main Business
- 5.13.3 Arxium Compounding Chemotherapy Products, Services and Solutions
- 5.13.4 Arxium Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.13.5 Arxium Recent Developments
- 5.14 Sterline S.R.L.
- 5.14.1 Sterline S.R.L. Profile
- 5.14.2 Sterline S.R.L. Main Business
- 5.14.3 Sterline S.R.L. Compounding Chemotherapy Products, Services and Solutions
- 5.14.4 Sterline S.R.L. Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.14.5 Sterline S.R.L. Recent Developments
- 5.15 Loccioni
- 5.15.1 Loccioni Profile
- 5.15.2 Loccioni Main Business
- 5.15.3 Loccioni Compounding Chemotherapy Products, Services and Solutions
- 5.15.4 Loccioni Compounding Chemotherapy Revenue (US$ Million) & (2016-2021)
- 5.15.5 Loccioni Recent Developments
6 North America
- 6.1 North America Compounding Chemotherapy Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Compounding Chemotherapy Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Compounding Chemotherapy Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Compounding Chemotherapy Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Compounding Chemotherapy Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Compounding Chemotherapy Market Dynamics
- 11.1 Compounding Chemotherapy Industry Trends
- 11.2 Compounding Chemotherapy Market Drivers
- 11.3 Compounding Chemotherapy Market Challenges
- 11.4 Compounding Chemotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Compounding Chemotherapy. Industry analysis & Market Report on Compounding Chemotherapy is a syndicated market report, published as Global Compounding Chemotherapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Compounding Chemotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
